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This review covers the literature published in 2003 for marine natural products, with 619 citations 
(413 for the period January to December 2003) referring to compounds isolated from marine 
microorganisms and phytoplankton, green algae, brown algae, red algae, sponges, coelenterates, 20 
bryozoans, molluscs, tunicates and echinoderms. The emphasis is on new compounds (656 for 
2003), together with their relevant biological activities, source organisms and country of origin. 
Biosynthetic studies or syntheses that lead to the revision of structures or stereochemistries have 
been included (78), including any first total syntheses of a marine natural product. 
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1 Introduction 45 
 
This review is of the literature for 2003 and describes 656 new compounds from 243 articles. These 
numbers are comparable to those of the past few years. We show structures only for new 
compounds, or for previously reported compounds where there has been a structural revision or a 
newly established stereochemistry. Previously reported compounds for which first syntheses or new 50 
bioactivities are described, are referenced, but separate structures are generally not shown. 
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2 Reviews 
 
A number of reviews have dealt with classes of compounds: “Sterols in microorganisms”,1 55 
“Bioactive macrolides and polyketides from marine dinoflagellates”,2 “Chemistry and biology of 
new marine alkaloids from the indole and annelated indole series”,3 “Brominated diterpenes of 
marine origin”,4 “Sulfur-containing natural products from marine invertebrates”,5 “The 
cerebrosides”,6 “Nonribosomal peptides from marine sponges”,7 “Bioactive polyhydroxysterols and 
their sapogenins from marine organisms”,8 “Sphingolipids from marine organisms”,9 “A review of 60 
research on the cyanotoxin cylindrospermopsin”,10 and “The manzamine alkaloids”.11  
Reviews that focus on bioactivity and development as drug candidates include: “Natural 
products as sources of new drugs over the period 1981-2002”,12 “Marine natural products as 
prototype agrochemical agents”,13 “Detection of pharmacologically active natural products using 
ecology”,14 “Marine pharmacology in 2000: antitumour and cytotoxic compounds”,15 “Bioactive 65 
natural products from marine invertebrates and associated fungi”,16 “Marine pyridoacridine 
alkaloids and synthetic analogues as antitumour agents”,17 “Drugs from the deep: marine natural 
products as drug candidates”,18 “Marine-derived anticancer agents in clinical trials”,19 “Marine 
natural products as lead anti-HIV agents”,20 “Natural products with anti-HIV activity from marine 
organisms”,21 “Algae, a possible source for new drugs in the treatment of HIV and other viral 70 
diseases”,22 and “Antimycobacterial natural products”.23  
Chemical synthesis is the theme of a number of reviews covering specific types of 
compounds through to more generally applicable methodology: “Total synthesis of (+)-
macrosphelides A, C, E, F and G based on enzymatic function”,24 “The total syntheses of 
phorboxazoles-new classes in natural product synthesis”,25 “The development of a practical total 75 
synthesis of discodermolide”,26 “Synthesis of the pyrrole-imidazole alkaloids”,27 “Chemistry of bis-
spiroacetal systems: natural products, synthesis and stereochemistry”,28 “Approaches towards the 
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synthesis of cephalostatins, ritterazines and saponins from Ornithogalum saundersiae”,29 “New and 
old challenges in total synthesis. From concept to practise”30 and “Microtubule-stabilizing marine 
metabolite laulimalide and its derivatives: synthetic approaches and antitumour activity”.31 80 
Other more general reviews include: “Molecular biodiversity. Case study: Porifera 
(sponges)”,32 “Microalgal metabolites”,33 “Enhancing marine natural product structural diversity 
and bioactivity through semisynthesis and biocatalysis”,34 and “Marine natural products”.35 
References to other reviews are more appropriately placed in the following sections. The Marinlit 
database36 continues to be updated and has again been used as the basis for the preparation of this 85 
present review. 
 
3 Marine micoorganisms and phytoplankton 
 
Probably the most important paper on marine microorganisms in 2003 was the first report on 90 
chemistry from the new obligate marine actinomycete taxon Salinospora.37 In excess of 2,500 
strains from this taxon have now been isolated and the potent proteasome inhibitor salinosporamide 
A 1 was isolated from a culture of a Salinospora sp. originating from a heat-treated marine 
sediment sample from the Bahamas. The structure of salinosporamide A, including the absolute 
stereochemistry, was deduced through spectral and X-ray analyses. Salinosporamide A displayed 95 
potent and selective in vitro cytotoxicity against cell lines in the NCI panel. Salinosporamide A also 
exhibited highly potent inhibition of the proteasomal chymotrypsin-like proteolytic activity of 
purified 20S proteasome. The unique functionalisation of the core-fused γ-lactam-β-lactone bicyclic 
ring structure of salinosporamide A 1 appears to contribute to its potency. The thiazolyl peptide 
antibiotics, nocathiacins I–III 2–4, have been isolated from the culture broth of Nocardia sp. (source 100 
not given).38 The nocathiacins exhibit potent in vitro activity against a wide range of bacteria, 
including several multiple-drug resistant pathogens and also exhibit excellent in vivo efficacy in a 
systemic Staphylococcus aureus infection mouse model.39 However, nocathiacin I 2 was found to 
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be identical to an antibiotic isolated from Amycolatopsis sp.40 but spectral data and stereochemical 
details had not been originally reported for this compound. Two cyclic thiopeptides 5 and 6, 105 
obtained from a culture of Bacillus cereus isolated from the marine sponge Halichondria 
japonica,41 exhibited potent antibacterial activities against Staphylococci and Enterococci sp., and 
were active against multiple-drug resistant strains.42 (6Z)-Geometry for these compounds was 
implied by ROESY correlations. 1H-15N HMBC analysis was used in determining the structure of 
bacillamide 7, a peptidic metabolite of an algicidal marine Bacillus sp. isolated during the 110 
termination of a bloom of Cochlodinium polykrikoides in Masan Bay, Korea.43 Bacillamide was 
shown to be active against a wide range of dinoflagellates and raphidophytes.44 Culture of an 
exocellular extract of a Pseudomonas sp. associated with Ircinia muscarum from the Bay of Naples, 
Italy gave the cyclotetrapeptide 8.45 The amino acid stereochemistry was established by standard 
methods (for example, chiral HPLC analysis of the acid hydrolysate, Marfey’s method etc). Four 115 
Streptomyces sp. of diverse origin yielded a range of metabolites. Firstly, culture of a Streptomyces 
sp. from a sediment sample from Oahu, Hawaii, yielded the antibacterial and antifungal metabolite 
bonactin 9.46 Parimycin 10, a new 1,4-anthraquinone, was isolated from a Streptomycete sediment 
sample from Laguna de Terminos, Gulf of Mexico. Parimycin had moderate activity against B. 
subtilis, Streptomyces viridochromogenes, S. aureus and E. coli, in addition to activity against a 120 
number of human tumour cell lines.47 A Streptomyces sp. cultured from an unidentified Mexican 
marine invertebrate yielded the cytotoxic indoles 11–13 which had moderate activity against a panel 
of 14 tumour cell lines.48 Finally, the anthracycline komodoquinone A 14 and the aglycone 
komodoquinone B 15 were isolated from a culture of a Streptomyces sp. isolated from marine 
sediment off Komodo Island, Indonesia. Komodoquinone A displayed dose-dependent neuritogenic 125 
activity against the neuroblastoma cell line Neuro 2A.49 A culture broth of an ATCC strain of the 
marine gliding bacterium Saprospira grandis yielded four neoverrucosane diterpenoids, 16–19. The 
relative and absolute stereochemistries of 16 were determined by standard methods50 (for example, 
X-ray analysis, NOESY and ROESY NMR experiments, the modified Mosher method, chiral 
 6 
HPLC, comparison of circular dichroism (CD) or other optical data against standards or model 130 
compounds etc).  The marine myxobacterium Haliangium ochraceum,51 originally H. luteum, 
yielded several new isomers of the polyene antifungal antibiotic haliangicin.52,53 These are cis-
haliangicin 20 and haliangicins B–D 21–23, geometrical isomers of the polyene and epoxide 
moieties. The stereochemistry of the epoxide in the known haliangicin 2453 has been determined as 
trans. All of the haliangicins were active against the phytopathogenic fungus Phytophthora 135 
capsici.54 Two siderophores, pseudoalterobactins A 25 and B 26, were isolated from a culture of the 
bacterium Pseudoalteromonas sp. isolated from the marine sponge Cinachyrella australiensis 
collected in Palau. Both compounds displayed strong binding affinity for the ferric ion in the 
chrome azurol S (CAS) assay.55 The bactericidal compound 27, obtained from a culture of a new 
marine species Pseudoalteromonas phenolica sp. nov., isolated from seawater collected off 140 
Ogasawara Island Japan,56 had potent activity against methicillin-resistant S. aureus (MRSA) and 
was also strongly active against Enterococcus serolicida, E. faecium and E. faecalis.57 This 
compound is available commercially, but this is the first reported isolation as a natural product. 
Cultures of two marine bacterial strains isolated from cultures of Pecten maximus larvae in Galicia, 
Spain, led to the first reported isolation, as natural products, of a series of DD-diketopiperazines 28–145 
31 and established them as potent inhibitors of the pathogenic marine bacterium Vibrio 
anguillarum. The structures were confirmed by synthesis.58 A cytotoxic polycyclic xanthone 32 has 
been isolated from the culture broth of the actinomycete Actinomadura sp.59 The phenoxazin-3-one 
antibiotics, chandrananimycins A–C 33–35, were also isolated from a culture of Actinomadura sp. 
derived from sediment from Jiaozhou Bay, China. Chandrananimycins A–C were active against 150 
human tumour cell lines while 35 exhibited potent activity against the fungus Mucor meihei and the 
bacteria B. subtilis and E. coli, and antialgal activity against the microalgae, Chlorella vulgaris, C. 
sorokiniana and Scenedesmus suspicatus.60 The fungus Aspergillus tamarii was isolated from 
driftwood collected in Okinawa and cultured to yield a pentacyclic oxindole alkaloid, speradine A 
36. The structure and relative stereochemistry of 36 were confirmed by X-ray analysis. Speradine A 155 
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exhibited inhibitory activity against histone deacetylase and antibacterial activity against 
Micrococcus luteus.61 A culture of the fungus Aspergillus ostianus, isolated from an unidentified 
marine sponge from Pohnpei, was the source of three chlorinated antibiotics, the asperlactone 
derivatives 37 and 38 and the aspyrone derivative 39. Compound 37 was the most potent, inhibiting 
the growth of the marine bacterium Ruegeria atlantica and that of E. coli and S. aureus to a lesser 160 
extent.62 Five novel depsipeptides, aspergillicins A–E 40–44, were obtained from a culture of 
Aspergillus carneus collected from estuarine sediment in Tasmania, Australia. The amino acid 
sequences were assigned by MSn ion-trap ESI mass spectrometry and stereochemistry was assigned 
by standard methodology. The aspergillicins exhibited modest cytotoxicity against Haemonchus 
contortus.63 A chiral dipyrrolobenzoquinone derivative, terreusinone 45, has been obtained from a 165 
cultured strain of the marine algicolous fungus Aspergillus terreus isolated from the surface of the 
marine red alga Halymenia acuminata collected from Bijin Island, South Korea. The absolute 
stereochemistry was determined by a combination of Horeau’s method and quantum chemistry 
calculations. Terreusinone has intense UV-A absorbtivity.64 A culture of Penicillium brocae from 
the tissue of the Fijian sponge Zyzzya sp. was the source of three novel cytotoxic polyketides, 170 
brocaenols A–C 46–48. These contain the unusual enolised oxepine lactone ring system. Structure 
determination included an INADEQUATE experiment on brocaenol A. The absolute 
stereochemistry of 46 was established by a standard method and extended to 47 and 48 by 
comparison of CD and optical rotation data.65 Brocaenols A–C displayed moderate activity against 
the HCT-116 cell line. Structures for brocaenols B and C were reversed in the original paper, but a 175 
correction has since been published.66 The steroids isocyclocitrinol A 49 and 22-
acetylisocyclocitrinol A 50 were extracted from a salt water culture of Penicillium citrinum isolated 
from Axinella sp. collected in Papua New Guinea.67 The absolute stereochemistry of 50 was 
established by standard methods, extended to 49, leading to the structural revision of cyclocitrinol, 
previously isolated from a terrestrial P. citrinum,68 to 51. Compounds 49 and 50 displayed weak 180 
antibacterial activity against Staphylococcus epidermidis and Enterococcus durans. The halovirs A–
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E 52–56, lipophilic linear peptides, are potent in vitro inhibitors of Herpes simplex viruses 1 and 2 
and were isolated from a Scytalidium sp. sourced from the Caribbean seagrass Halodule wrightii.69 
Two cyclic heptapeptides, scytalidamides A 57 and B 58, have been isolated from the culture broth 
of another Scytalidium sp. derived from the surface of the green alga Halimeda sp. collected off the 185 
Bahamas. The absolute configurations were confirmed by standard methods including CD 
measurements. Both scytalidamides displayed moderate cytotoxicity to the HCT-116 cell line in 
vitro.70 Trichodermamides A 59 and B 60, modified dipeptides, were isolated from cultures of 
Trichoderma virens isolated from the ascidian Didemnum molle and from the surface of a green 
alga of the genus Halimeda, both collected in Papua New Guinea. The ascidian-derived culture 190 
contained trichodermamide A with traces of trichodermamide B while a greater quantity of 
trichodermamide B was isolated from the algal-derived strain. The structure of 59 was assigned by 
X-ray diffraction while the absolute stereochemistry was determined using the modified Mosher 
method. Trichodermamide B displayed significant in vitro cytotoxicity against HCT-116 and 
moderate antimicrobial activity against amphoterocin-resistant C. albicans, MRSA and 195 
vancomycin-resistant E. faecium.71 Trichodermamide A is closely related to penicillazine, reported 
from a marine-derived Penicillium sp.72 The reported structures differ only in the translocation of 
ester and amide bonds, but spectral data comparison suggests that these compounds may be 
identical. Two macrolides, modiolides A 61 and B 62, and a linear pentaketide modiolin 63 have 
been isolated from the culture of Paraphaeosphaeria sp. separated from the marine horse mussel 200 
Modiolus auriculatus, collected in Okinawa. The absolute stereochemistry of 61 was determined by 
the exciton chirality method73 using a p-methoxycinnamoyl ester, while the absolute 
stereochemistry of 63 was defined by the modified Mosher method. Modiolides A and B exhibited 
modest antibacterial activity against Micrococcus luteus and Neurospora crassa.74 A culture of the 
marine fungus Wardomyces anomalus, isolated from the green alga Enteromorpha sp. collected in 205 
the Baltic Sea, yielded two xanthone derivatives, anomalin A 64 and B 65.75 The anomalins were 
only weakly antimicrobial, but anomalin A possessed significant tyrosine kinase p56lck enzyme 
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inhibitor activity and antioxidative properties. Remisporine A 66, a novel cyclopentachromenone, 
isolated from a culture of the marine fungus Remispora maritima from an unspecified wood source, 
is unstable under normal conditions and autocatalytically dimerises stereospecifically, via a Diels-210 
Alder reaction, to remosporine B.76 A new anthraquinone, evariquinone 67, and the new 
prenylxanthone isoemericellin 68 were isolated from a culture of the fungus Emericella variecolor 
derived from the marine sponge Haliclona valliculata collected at Elba, Italy. The known C-
glycosidic depside stromemycin 6977 was also isolated, and the previously undescribed double bond 
configurations established. Evariquinone 67 showed antiproliferative activity towards KB and NCI-215 
H460 cells.78 A culture of a marine strain of the fungus Epicoccum purpurascens, isolated from 
inner tissue of the jellyfish Aurelia aurita collected from the North Sea, Germany, yielded the 
tetramic acid derivative epicoccamide 70. Attempts to resolve the stereochemistry at C-4 and C-8 
by comparision of CD spectra with those of similar compounds were ambiguous.79 Two highly 
oxygenated polyketides, phomoxin 71 and phomoxide 72, are metabolites from a Phoma sp. 220 
isolated from a microbial mat collected from a Bahaman hypersaline pond, along with eupenoxide 
73, a previously synthesised, but unpublished fungal metabolite.80 An actinomycete, 
Pseudonocardia sp., isolated from littoral sediment from Mauritius, Indian Ocean, was the source 
of a new phenazine derivative, phenazostatin D 74 which is the meso- form of the known antibiotic 
phenazostatin B.81,82 Investigations of a collection of Lyngbya majuscula from Puerto Rico resulted 225 
in the isolation of three new metabolites, a quinoline alkaloid, 75, malyngamide T 76 and a 
tryptophan derivative 77.83 Geometries for the vinyl chloride functionalities of 75 and 76 were 
established as (E) by 1H-13C coupling constant measurement from HSQMBC NMR experiments.84 
Six cyclic depsipeptides, guineamides A–F 78–83, were isolated from a collection of Lyngbya 
majuscula collected from Papua New Guinea. Absolute stereochemistries for most of the amino 230 
acids were determined by standard methods. Guineamides B and C were moderately cytotoxic to a 
mouse neuroblastoma cell line.85 L. majuscula from Papua New Guinea was the source of the novel 
cyclic dodecapeptide wewakazole 84 which contains an unprecedented number of five-membered 
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heterocyclic rings (six). Due to extensive signal overlap the structural assignment required multiple 
NMR and MS/MS experiments. The absolute stereochemistry was determined by standard 235 
methods.86 L. majuscula from the southern Kenyan Coast was the source of the cyclic depsipeptide 
homodolastatin 16 85. The absolute stereochemistries of most of the amino acids in homodolastatin 
16 were determined by standard methods. Homodolastatin 16 85 displayed moderate activity 
against oesophageal and cervical cancer cell lines.87 The cyclic peptide lyngbyastatin 3 86, isolated 
from L. majuscula collected from Guam, contains two unusual amino acid units, including 4-amino-240 
2,2-dimethyl-3-oxopentanoic acid (Ibu). The configuration of the Ibu unit was established by acid 
hydrolysis and comparison with synthetic standards, while the absolute stereochemistries of the 
remaining residues were determined by standard methods. Lyngbyastatin 3, along with the 
previously isolated lyngbyastatin 1 and dolastatin 12,88 are in fact diastereotopic mixtures of both 
Ibu epimers. Lyngbyastatin 3 86 exhibited activity against KB and LoVo cell lines in vitro, but was 245 
poorly tolerated in vivo with little antitumour activity.89 Three new malyngamides, U–W 87–89, 
have been isolated from L. majuscula collected in Papua New Guinea. Partial relative 
stereochemistries only were determined.90 A collection of Lyngbya sp. from Palau yielded 
ulongapeptin 90, a cytotoxic cyclic depsipeptide,91 while a Lyngbya sp. from Guam yielded two 
new compounds, 15-norlyngbyapeptin A 91 and lyngbyabellin D 92.92 The absolute 250 
stereochemistries in each case were determined through degradative studies and/or comparison with 
commercially available and synthetic standards. Ulongapeptin was moderately cytotoxic against KB 
cells in vitro91 and lyngbyabellin D displayed activity against the KB cell line.92 Bioassay-guided 
fractionation of an extract from a Lyngbya sp. collected in Palau led to the isolation of palau’amide 
93. Effective use was made of a band-selective HMBC experiment to unambiguously assign 13C 255 
NMR signals that were separated by only 0.1 ppm.93 Except for C-37, relative and absolute 
configurations were determined by standard methods. By modelling, and from NOE data, C-37 was 
assigned as having the (S) configuration. Palau’amide 93 exhibited potent cytotoxicity against KB 
cells.94 Semiplenamides A–G 94–100, anandamide-like fatty acid amides, were isolated from a 
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collection of Lyngbya semiplena collected in Papua New Guinea. The absolute stereochemistries of 260 
the amino alcohols in semiplenamides C–E 96–98 were elucidated as all L by chemical 
derivatisation and chiral GCMS methods. All of the semiplenamides displayed toxicity in the brine 
shrimp assay, while semiplenamides A, B and G exhibited weak affinity for the rat cannabinoid 
CB1 receptor. Semiplenamide A was also a moderate inhibitor of the anandamide membrane 
transporter (AMT).95 Samples of the marine cyanobacterium Symploca sp. collected in Palau were 265 
the source of the depsipeptides tasipeptins A 101 and B 102,96 and a cytotoxic peptide, tasiamide B 
103.97 The relative and absolute configurations of the tasipeptins and tasiamide B were determined 
by standard methods except for the configuration of C-28 in tasiamide B. This was tentatively 
suggested as (S) from NMR data analysis.97 Both tasipeptins exhibited moderate cytotoxicity 
towards KB cells in vitro. Also collected in Palau was an assemblage of a Symploca sp. 270 
cyanobacterium and an unidentified red alga. From this was isolated the iodinated diterpenes, 
tasihalides A 104 and B 105. These compounds possess a novel cage structure with both an 
oxabicyclic ring system and a cis-decalin system. These are the only examples of iodinated 
diterpenes in nature. Since terpenoids are almost never reported from marine cyanobacteria, but 
halogenated terpenes are ubiquitous in red algae, the authors speculate that the more likely source of 275 
the tasihalides is the alga and not the cyanobacterium.98 Two polyunsaturated monocyclic 
triterpenes 106 and 107 have been isolated from a culture of the common marine diatom 
Rhizosolenia setigera. The structure of a related monocyclic sesterterpene 108 was also proposed on 
the basis of mass spectral comparisons with compounds 106 and 107.99 Amphidinolide X 109100 
and amphidinolide Y 110101 are cytotoxic 16- and 17-membered macrodiolides isolated from 280 
cultures of the marine dinoflagellate Amphidinium sp., originally separated from the inside cells of 
the marine acoel flatworm Amphiscolops sp. collected from Okinawa. Amphidinolide Y exists as a 
9:1 equilibrium mixture of the 6-keto- 110 and 6(9)-hemiacetal 111 forms. Both amphidinolides X 
and Y were moderately cytotoxic against murine lymphoma L1210 and human epidermoid 
carcinoma KB cells in vitro.  Feeding experiments with 13C-labelled acetates suggested that 285 
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amphidinolide Y might be a precursor of amphidinolide X.101 A culture of the dinoflagellate 
Symbiodinium sp., a symbiont of the soft coral Clavularia viridis collected from Okinawa, yielded 
two diastereoisomeric norcarotenoids 112 and 113. Both compounds exhibited moderate growth-
inhibitory activity in vitro against a range of human cancer cell lines.102 A culture of the free-living 
marine dinoflagellate Symbiodinium sp. isolated from a tide pool, Coconut Island, Hawaii,103 290 
yielded the polyhydroxy compound zooxanthellamide A 114.104 Cultures of a strain of the 
dinoflagellate Prorocentrum lima105 afforded okadaic acid methyl ester 115, norokadanone 116 and 
an okadaic acid diol ester 117.106 Three hydroxybenzoate saxitoxin analogues, GC1–GC3 118–120, 
have been isolated from the cultured dinoflagellate Gymnodinium catenatum originally isolated 
from a planktonic bloom in Tasmania. GC1 and GC2 are the epimeric 11-hydroxysulfate 295 
derivatives of GC3, the 4-hydroxybenzoate ester derivative of decarbamoylsaxitoxin. Preliminary 
investigations indicate that the compounds bind to rat brain sodium channels, in keeping with 
known PSP toxins.107 Biosynthetic investigations using 13C-labelled precursors of the 
meroterpenoid neomarinone, originally isolated from culture of an unidentified marine 
actinomycete from sediment from Batiquitos Lagoon, California,108 led to the structural revision of 300 
neomarinone to 121.109 A correction to the text of the article describing the structure and absolute 
stereochemistry of phormidolide from the marine cyanobacterium Phormidium sp.110 has been 
published, amending two descriptors [(17R,26R) to (17S,26S)].111 The absolute configuration of the 
fungal metabolite phomopsidin 122, derived from a cultured strain of Phomopsis sp.,112 has been 
determined by the exciton chirality method. Phomopsidin exhibited potent anti-microtubule activity 305 
in a microtubule assembly assay utilising purified porcine brain microtubule proteins.113 A total 
synthesis of petrobactin, a siderophore isolated from the marine bacterium Marinobacter 
hydrocarbonoclasticus has been completed. Comparison of the 1H NMR spectrum of the synthetic 
product with literature data for the natural product114 resulted in a structural revision of petrobactin 
from 2,3-dihydroxybenzoyl- to 3,4-dihydroxybenzoyl-moieties. This 3,4-dihydroxybenzoyl 310 
analogue 123 was also synthesised, giving 1H and 13C NMR spectra that were consistent with those 
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of the natural product.115 The first total synthesis of yanucamide A 124, which was isolated from an 
assemblage of L. majuscula and a Schizothrix species,116 has been achieved via amide and ester 
coupling methods. The synthesis established the configuration at C-3, originally unassigned due to 
ambiguity, and revised the configuration at C-22.117 In synthetic studies towards congeners of 315 
phomactin A, total syntheses of structures isomeric to that proposed for the phomactin known as 
Sch 49028, also isolated from the marine fungus Phoma sp.,118 are described. None of the isomers 
showed spectral data consistent with those of the natural product so it is proposed that Sch 49028 
does not exist and that the NMR spectral data should have been assigned as phomactin A.119 Other 
first total syntheses reported include that of (±)-spiroxin C, originally isolated from culture of an 320 
unidentified fungal strain from a soft coral from Vancouver Island, Canada.120 This involved a 
Suzuki-Miyaura cross-coupling reaction.121 Apratoxin A, a cyclodepsipeptide from Lyngbya sp. 
collected in both Guam122 and Palau,123 has been synthesised.124 The relative and absolute 
stereochemistries of amphidinoketide I 125, originally isolated from the dinoflagellate Amphidinium 
sp. collected in the Virgin Islands,125 have been determined by total synthesis of all four 325 
diastereoisomers. Molecular modelling was used to infer that the natural product is not the 
thermodynamically preferred diastereoisomer.126 Two syntheses of the 19-membered macrolide (+)-
amphidinolide T1127,128 have been achieved,129,130 along with the synthesis130 of amphidinolides 
T3131 and T5.128 Synthesis of the structurally complex gymnocin-A, a polyether toxin with 14 
contiguous rings, from the red tide dinoflagellate Karenia mikimotoi,132 has been accomplished 330 
through the use of B-alkyl Suzuki-Miyaura coupling-based methodology.133 Following the first total 
synthesis of gambierol, a marine polycyclic ether toxin originally isolated from the marine 
dinoflagellate Gambierdiscus toxicus,134 preliminary structure-activity relationship studies suggest 
that functionalities in the H ring and unsaturated sidechain are essential for potent murine 
toxicity.135 A competitive inhibition assay using the isotopically labelled brevetoxin dihydro BTX-B 335 
([3H]PbTx-3), demonstrated that gambierol134,136 and gambieric acid-A137,138 from the dinoflagellate 
Gambierdiscus toxicus inhibit the binding of brevetoxins to site 5 of the voltage-gated sodium 
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channel of excitable membranes,139 while effects of brevetoxins produced by the dinoflagellate 
Karenia brevis (formerly Ptychodiscus breve and Gymnodinium breve)140 on the murine myeloma 
cell line SP2/O, a possible model for in vitro studies for immune cells, suggest that the brevetoxins 340 
have an aberrant effect on cell division.141 
 
4 Green algae 
 
As in 2002, very few new compounds have been reported from green algae. The cyclic depsipeptide 345 
kahalalide F 126, originally isolated from both the mollusc Elysia rufescens and from the dietary 
source, the green alga Bryopsis sp.,142 was introduced into Phase I trials by Pharma Mar SA as a 
lead compound against prostate cancer. The structure of kahalalide F has been corrected based on a 
series of degradation reactions. The planar structure only was originally defined and the 
stereochemistry subsequently assigned.143 The degradation results indicate that the correct structure 350 
is a stereoisomer 126, in which the original assignments for Val-3 and Val-4 have been reversed. 
This stereochemistry is crucial for the observed bioactivity.144 Twelve new terpene esters, 127–138 
have been isolated from the green alga Caulerpa prolifera collected from Saronicos Gulf, Greece. 
The C. prolifera extract exhibited moderate to significant activity against three unidentified strains 
of marine bacteria, in addition to strong growth inhibitory effects on the fouling microalga 355 
Phaeodactylum tricornutum.145 The first total synthesis of (±)-dihydrorhipocephalin, a bioactive 
sesquiterpene isolated from Caribbean marine green algae of the genera Penicillus and Udotea,146 
has been reported.147 
 
5 Brown algae 360 
 
A wider range of compounds has been reported from brown algae in 2003 than in 2002, when 
terpenes and steroids were the predominantly reported compound classes. Six tetraprenyltoluquinols 
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139–144, two triprenyltoluquinols 145 and 146 and two tetraprenyltoluquinones 147 and 148 were 
isolated from the brown alga Cystoseira crinita collected from the south coast of Sardinia. All 365 
compounds were tested for antioxidative properties in the α,α-diphenyl-β-picrylhydrazyl radical 
(DPPH) and thiobarbituric acid reactive substances (TBARS) assay systems. Compounds 139–146 
exhibited potent radical-scavenging effects while 147 and 148 were significantly less active, but 
still comparable to that of butylated hydroxytoluene (BHT). The radical scavenging activity of 
compounds 142, 144 and 148 was further assessed using the Trolox equivalent antioxidant capacity 370 
(TEAC) and photochemiluminescence (PCL) assays that confirmed the potent radical scavenging 
ability. Compounds 139 and 140 were moderately cytotoxic against several carcinoma cell lines.148 
Four hydroazulene diterpenes, dictyone acetate 149, dictyol F monoacetate 150, isodictytriol 
monoacetate 151 and cystoseirol monoacetate 152, were isolated from the brown alga Cystoseira 
myrica collected in the Gulf of Suez. All four compounds exhibited moderate cytotoxicity against 375 
the murine cancer cell line KA3IT, but reduced cytotoxicity against normal NIH3T3 cells.149 
Dictyone acetate along with a pachydictyol A derivative 153 (incorrect structures shown in original 
reference) were also isolated from the brown alga Dictyota dichotoma collected from the Red 
Sea.150 D. dichotoma from the Arabian Sea was the source of two seco-dolastanes dichotone 154 
and dichotodione 155,151 two dolastane diterpenoids, dichototetraol 156 and dichopentaol 157,152 380 
and the related dichotenones A 158 and B 159, two enone dolastane diterpenoids.153 The 
configurations of 154 and 155 were determined by comparison of spectral data against those of 
known compounds. The new diterpene dictyocrenulol 160 was isolated from the brown alga 
Dictyota crenulata collected from Easter Island.154 Eisenia bicyclis collected at Johgashima Island, 
Japan, was the source of nine novel oxylipin compounds 161–169.155 Five of these, eiseniachlorides 385 
A–C 161–163 and eiseniaiodides A 164 and B 165, are ecklonialactone derivatives and two more, 
166 and 167, are cymathere type oxylipins. Stereochemistries of compounds 161–165 and 169 were 
elucidated by NMR analyses, but the relative stereochemistry at C-9 in 168 could not be determined 
unambiguously. Olefin geometry in 166 was ambiguous, but considered to be (Z) on biosynthetic 
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grounds, and at least one olefin in compound 167 was (Z). A 22-membered cyclic lactone, 390 
lobophorolide 170, was isolated from the common brown alga Lobophora variegata, collected at 
several reef locations in the Bahamas and from the Red Sea. The structure was elucidated by 
spectral data analysis and comparison against data published for tolytoxin156 and swinholide A.157,158 
It is proposed that lobophorolide and tolytoxin share the same relative configuration at all 
stereogenic centres in the macrolide portion of the molecule, while a (6R) configuration is 395 
suggested for both compounds rather than the (6S) configuration proposed previously for 
tolytoxin.156 The absolute configuration of lobophorolide is proposed to be the same as that of 
tolytoxin based on optical rotation. Lobophorolide 170 displayed potent and highly specific activity 
against the marine filamentous fungi Dendryphiella salina and Lindra thalassiae in addition to 
potent activity against C. albicans and antineoplastic activity against the HCT-116 cell line.159 The 400 
brown alga Sargassum asperfolium, collected in the Suez Gulf, was the source of the steroidal 
metabolite saringosterone 171,160 while a novel steroid 172 has been isolated from the brown alga S. 
carpophyllum from the South China Sea.161 Ecklonia stolonifera collected from S. Korea yielded a 
new phlorotannin, eckstolonol 173, which possessed potent DPPH radical scavenging activity.162 
Dolabellane 1, originally isolated from the opistobranch mollusc Dolabella californica,163 has been 405 
characterised as the major secondary metabolite and active chemical defense agent against 
herbivores (sea urchins and fish) in the brown alga Dictyota pfaffi.164 (±)-Hedaol B, a 
bisnorditerpene isolated from the Japanese brown alga Sargassum sp.,165 has been synthesised with 
geranyl acetone as a starting material and alkylation of silyl cyanide as the key step in the 
synthesis.166 410 
 
6 Red algae 
 
The genus Laurencia continues to be a prolific source of new metabolites. A brominated bisabolene 
derivative, aldingenin A 174, was isolated from Laurencia aldingensis collected from Brazil. 415 
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Biogenetic considerations were of value in the structural assignment.167 From L. microcladia from 
Elba Island, a calenzanane sesquiterpene, debromoisocalenzanol 175 and an indene-type 
sesquiterpene 176 were isolated,168 while four new sesquiterpenes, 177–180 including the snyderol 
derivatives 179 and 180, have been isolated from L. obtusa collected from Bademli, Turkey. 
Compound 179 was active against D6 and W2 clones of the malaria parasite Plasmodium 420 
falciparum.169 Laurencia perforata, collected from the Great Barrier Reef, Australia, was the source 
of the sesquiterpenes 4-hydroxy-1,8-epi-isotenerone 181 and two 3-epi-perforenone A derivatives, 
182 and 183.170 A collection of L. obtusa from Greece yielded four new brominated diterpenes,171  
prevezols C–E 184–186, and neorogioldiol B 187, together with the known prevezol B 188, whose 
structure has been revised from that reported originally.172 Prevezol B and neorogioldiol displayed 425 
significant cytotoxicity against the human tumour cell lines MCF7, PC3, HeLa, A431 and K562 
while prevezol C only exhibited significant cytotoxicity against HeLa and A431 cell lines. Prevezol 
D was moderately active against all cell lines.171 Two labdane type brominated diterpenes 189 and 
190 have been isolated from L. obtusa from Greece. These structures contain unprecedented eight- 
and seven-membered ether rings respectively.173 Six new bromophenols, 191–196 were isolated 430 
from Rhodomela confervoides collected from the coast of Qingdao, China.174 Compounds 193 and 
195 may be artifacts of the extraction and isolation processes.174 Compounds 194 and 195 were also 
reported in another paper by the same authors, along with the isolation of the known 3-bromo-4,5-
dihydroxybenzoic acid methyl ester (but new as a natural product) from the same source (R. 
confervoides).175 This benzoyl ester has previously been synthesised176 but the spectral data were 435 
not reported. R. confervoides from Qingdao was also the source of bromophenols, 197 and 198. The 
phenol 198, which might also be derived from 197 during isolation,177 exhibited moderate activity 
against five strains of bacteria.178 Five monoterpenes 199–203 of the ochtodane class have been 
isolated from the red alga Portieria hornemanni (source not given).179  The marine polyether 
triterpenoid dehydrothyrsiferol, originally isolated from the red alga Laurencia pinnatifida,180 was 440 
shown to induce apoptosis in estrogen-dependent and independent breast cancer cells.181 Elatol, a 
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halogenated sesquiterpene alcohol from the red alga L. elata182 inhibited six species of human 
pathogenic bacteria, with significant antibacterial activities against Staphylococcus epidermis, 
Klebsiella pneumonia and Salmonella sp.183 Iso-obtusol from the red alga Laurencia obtusa184,185 
exhibited antibacterial activity against four bacterial species with significant activity against K. 445 
pneumonia and Salmonella sp. Further tests indicated that both compounds were bacteriostatic 
rather than bacteriocidal against the bacteria tested.183 Glutathione transferase specific activity in 
Katharina tunicata (black chiton) was shown to be affected by the brominated phenol lanosol,186 
which is prevalent among filamentous red algae of the Rhodomelaceae, and frequently consumed 
by K. tunicata.187 The first asymmetric total syntheses of (+)-3-(E)- and (+)-3-(Z)-pinnatifidenyne, 450 
originally isolated from Laurencia pinnatifida,188,189 have been reported and utilise an “olefin 
geometry-dependent” internal alkylation to give excellent stereoselectivity.190 The seven-membered 
ring ether (+)-neoisoprelaurefucin 204, originally isolated from L. nipponica,191 has also been 
synthesised, allowing the assignment of the absolute stereochemistry of the natural product.192 A 
nickel-catalysed coupling reaction of an alkynyl enone and an alkenylzirconium were the key steps 455 
in the synthesis of isodomoic acid G 205, originally isolated from the red alga Chondria armata 
from Kyushu Island.193 The sidechain stereochemistry was established as (5’R) by comparison of 
CD spectra of the natural and synthetic products.194 
 
7 Sponges 460 
 
Sponges continue to be an important source of novel secondary metabolites and a notable growing 
trend is the characterisation of compounds from bacteria and fungi that have been isolated from 
sponges. Such compounds have been included in Section 3 of this review. There has also been 
increased interest in fatty-acid derivatives, many of which have biological activities. An unusual 465 
galactofuranosylceramide, ectyoceramide 206, was isolated from the Bahaman sponge Ectyoplasia 
ferox,195 while a Jaspis species collected in Vanuatu was found to contain the cytotoxic sphingosine 
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derivatives jaspines A 207 and B 208.196 The Korean sponge Erylus nobilus was the source of the 
taurine derivative 209.197 Another Korean sponge, a Stelletta species, has yielded two cytotoxic 
compounds, glycerol ether 210198 and cyclitol derivative norsarcotride A 211.199 Plakevulin A 212, 470 
found to inhibit DNA polymerases α and γ, was isolated from the Okinawan sponge Plakortis sp.200 
Latrunculia corticata, collected in the Gulf of Aqaba, Israel, was found to contain decalactone 
glycosides latrunculinoside A 213 and B 214, which have anti-feedant activity against goldfish.201 
An inhibitor of membrane type 1 matrix metalloproteinase (MT1-MMP), callysponginol sulfate A 
215, was isolated from Callyspongia truncata collected in Japan.202 An undescribed Korean species 475 
of Stelletta was found to contain cytotoxic acetylenic acids: stellettic acid A 216, (Z)- and (E)-
stellettic acid B 217 and 218, and stellettic acid C 219 that exhibited marginal to moderate toxicity 
to five human tumour cell lines.203 Interestingly, the same sponge also yielded the glycerol 
derivatives of 217, the mildly cytotoxic 220 and 221 (inactive), along with other 
lysophosphatidylcholines and monoglycerides 222–225.204 From a seemingly identical Stelletta 480 
species, collected at a different Korean location, a similar series of acetylenic acids was isolated 
including 216, a dimeric anhydride 226 and a desmethoxy analogue 227; all were mildly cytotoxic 
to human leukemia cells.205 The Indonesian sponge Callyspongia pseudoreticulata yielded the 
diyne 228, which was found to be toxic in the brine shrimp assay.206 A Diplastrella species, 
collected in the Philippines, yielded a series of polyacetylenic diols, the diplynes A–E 229–233 and 485 
corresponding sulfates 234–236.207 Three new chlorinated polyacetylenes 237–239 were isolated 
from the Californian sponge Haliclona lunisimilis208 along with known compounds originally 
isolated from the Haliclona’s nudibranch predator, Diaulula sandiegensis.209 The moderately 
cytotoxic polyacetylenic amide, callyspongamide A 240, was obtained from Callyspongia fistularis 
collected in the Red Sea.210 Three new amides, 241–243, along with the previously reported 490 
clathrynamide A 244,211 were isolated from an Okinawan Psammoclemma species. 212 The 
stereochemistry of 244 was determined (Mosher method). All four compounds were found to be 
antifungal. The absolute stereochemistry of the amino alcohol xestoaminol C, originally isolated 
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from a Fijian Xestospongia species,213 has been established as (2S,3R) by the synthesis of the N,O-
diacetyl derivative from (S)-alanine.214 A racemic synthesis of 2-methoxy-13-methyltetradecanoic 495 
acid, isolated from a Puerto Rican specimen of Amphimedon complanata,215 has been reported.216 
(R)-Strongylodiol B, originally isolated from a Strongylophora species,217 was synthesised 
enantioselectively using a Zn(II) acetylide addition to an aldehyde.218 Callyberynes A and B, also 
known as callypentaynes, obtained from Japanese specimens of Callyspongia truncata219 and 
Callyspongia sp.,220 were synthesised using sequential Cadiot-Chodkiewicz cross-coupling 500 
reactions.221 Erylus trisphaerus, collected in Dominica, was found to contain the mildly cytotoxic 
polyketide lactone, trisphaerolide A 245.222 A Madagascar specimen of Plakortis aff. simplex 
yielded three cyclic peroxides, the plakortolides H 246 and I 247 and andavadoic acid 248, all of 
which were cytotoxic against a range of human tumour cell lines.223 The antimicrobial tetramic 
acid, melophlin C 249, from an Indonesian specimen of Melophlus sarassinorum, was isolated as 505 
an inseparable mixture of four stereoisomers arising from the stereogenic centres at C-5 and C-10 
(as evidenced by NMR and modified Marfey’s method). A further twelve, less active tetramic 
acids, melophlins D–O 250–261, were also isolated from the same sponge.224 Both plakortides M 
262 and N 263, isolated from a collection of Plakortis halichondrioides from Puerto Rico, 
exhibited potent cytotoxicity to an array of human tumour cell lines.225 A Japanese specimen of 510 
Monotria japonica yielded the monotriajaponides A–D 264–267 which can lyse starfish oocytes 
without disruption of nuclear structure.226 Interestingly, the absolute stereochemistries of 265–267, 
as determined by reduction and a modified Mosher method, were opposite to those determined for 
the plakortides 262 and 263. The asymmetric synthesis of (+)-rottnestol, originally isolated from a 
Haliclona species,227 using a Stille coupling firmly established the absolute stereochemistry as 515 
(12R). Similarly, syntheses of (+)-raspailol A and (+)-raspailol B, originally obtained from a 
Raspailia species,228 have established a (12R) configuration for these two metabolites also.229 An 
unusual bis-dimedone thioether with strong UV A and B absorption, benzylthiocrellidone 268, was 
isolated from a Great Barrier Reef collection of Crella spinulata; the structure was reported in 
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2002,230 but was omitted from the 2002 review.231 Okadaic acid, originally isolated from 520 
Halichondria okadai,232 and subsequently found to be a dinoflagelate and shellfish toxin,233,234 has 
been investigated for potential as a defense molecule for the Adriatic sponge Suberites domuncula. 
Use of an ELISA assay established that okadaic acid was localised in the epithelium of the lacunae 
and water channels of the sponge, as well as in bacteria located in the sponge tissue. It was 
postulated that okadaic acid acts as a stimulant of the sponge immune system to the presence of 525 
bacteria, but in higher concentrations causes apoptosis.235 Two analogues of okadaic acid, 27-O-
acetylokadaic acid 269 and 27-O-acetyldinophysistoxin 1 270, were isolated from a British 
Columbian sponge Merrianum oxeato and found to be potent G2 checkpoint inhibitors and highly 
cytotoxic.236 A Papua New Guinean sponge, Cymbastela sp., was found to contain the cytotoxic 
peptide milnamide D 271 along with the related peptides hemiasterlin237 and milnamide A.238 All 530 
three compounds were inhibitors of tubulin polymerisation.239 Three unusual new cyclic peptides, 
the kapakahines E–G 272–274, have been isolated from a Micronesian collection of Cribrochalina 
olemda and reported as cytotoxic to P388 murine leukemia cells.240 The previously described 
sulfoxide, waiakeamide 275, and a new sulfone analogue 276 were isolated from a Haliclona sp. 
collected in Palau. The sulfone 276 was found to inhibit the settlement of larvae of the blue mussel 535 
(Mytilus edulis galloprovincialis).241 The myriastramides A–C 277–279 were isolated from the 
same Philippine collection of Myriastra clavosa that had previously yielded the clavoside 
macrolides.242,243 Leucamide A, originally isolated from the Australian sponge Leucetta 
microraphis,244 has been synthesised.245 Due to differences in biological activity, the cis,cis- 280 
and reputed trans,trans- 281 isomers of ceratospongamide, originally isolated from the Indonesian 540 
symbiotic pairing of the red alga Ceratodictyon spongiosum and the sponge Sigmadocia 
symbiotica,246 continue to attract considerable attention from synthetic chemists. Although both 
rotamers had been synthesised previously,247 slight differences in the NMR spectra of the synthetic 
trans,trans isomer 281 and the isolated natural product were noted. Suspecting a possible 
epimerisation the trans,trans-[D-allo-Ile] isomer, 282 was synthesised, by two separate routes, to 545 
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produce a compound that is identical in all respects to the natural isomerisation product.248 
Phakellistatins 1249 and 10,250 have been synthesised.251 Phakellistatin 1 was found to exist as the 
all-cis rotamer at the proline residues, while phakellistatin 10 was determined to be all-trans. 
Interestingly, both synthetic products were more than 100-fold less cytotoxic than the natural 
product.251 A large (500 Kg) collection of a Phakellia species from Chuuk, Micronesia, yielded the 550 
growth inhibitory phakellistatin 12 283,252 while a Chinese collection of Phakellia fusca yielded the 
very cytotoxic phakellistatin 13 284.253 The macrolide spirastrellolide A was isolated as its methyl 
ester 285 from the Caribbean sponge Spirastrella coccinea. Unlike many other sponge-derived 
antimitotic macrolides, 285 does not effect tubulin polymerisation.254 An asymmetric synthesis of 
(–)-peloruside A, the antipode of the natural product 286 originally isolated from the New Zealand 555 
sponge Mycale hentscheli,255 has been achieved via a Mitsunobu-type lactonisation.256 The 
synthetic antipode proved to be biologically inactive in cytotoxicity assays, but established the 
absolute stereochemistry of the natural (+)-enantiomer 286 as drawn. The relative and absolute 
stereochemistries of the C23-C35 portion of reidispongiolide A 287, isolated from the New 
Calidonean sponge Reidispongia coerulea,257 have been established by synthesis of an ozonolysis 560 
fragment of the natural product.258 The total synthesis of (+)-13-deoxytedanolide, originally 
isolated from the Japanese sponge Mycale adherens,259 has been accomplished.260 The natural 
enantiomer of lasonolide A, isolated from a Caribbean Forcepia species,261 has also been 
synthesised and found to be bioactive.262 The hexabromobiphenylether from Dysidea herbacea263 
has been synthesised and found to be a potent aldose reductase (ALR2) inhibitor.264 The 565 
Micronesian sponge Cribrochalina olemda was found to contain a new N-methyl-D-aspartate 
(NMDA) receptor ligand, cribronic acid 288, which has potent convulsant activity in mice.265 The 
known antioxidant amino acid L-5-hydroxytryptophan was found to be a major constituent of the 
NW Atlantic intertidal sponge Hymeniacidon heliophila and was observed to suppress apoptosis in 
human lymphocytes at concentrations similar to those found in the sponge tissue. Since UV light 570 
induces apoptosis, it is proposed that the high concentrations of L-5-hydroxytryptophan act to 
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protect this sponge species from sunlight UV damage.266 The pyridinium alkaloid simplakidine A 
289 was isolated from the Caribbean sponge Plakortis simplex.267 The rather remarkable tris-
pyridinium alkaloid viscosamine 290 has been isolated from the Arctic sponge Haliclona viscose. 
The trimeric nature of this alkaloid was deduced from a series of ions in the mass spectrum.268 575 
Halitulin 291, isolated from a South African collection of Haliclona tulearensis,269 has been 
synthesised, establishing C-15 as (S).270 Clathryimine, originally isolated from Clathria basilana,271 
has been synthesised using palladium-catalyzed cross-coupling reactions.272 Hachijodines F and G, 
isolated originally from Xestospongia and Amphimedon species,273 have been synthesised. The N-
oxide moieties were introduced using modified Mukiyama conditions.274 Pyrinodemin A 292, 580 
isolated from a Okinawan collection of an Amphimedon species,275 continues to attract considerable 
attention from synthetic organic chemists.231 The position of the cis double bond has been 
contentious, with the originally published structure 292 being modified to 293276 and 294277 
respectively. The structure 294 has now been synthesised asymmetrically by two independent 
groups establishing the absolute stereochemistry of the bicyclic core.278,279 One group was also able 585 
to compare the spectral data to the original spectra of the natural product and confirm the structure 
as 294.278 Petrosin and petrosin A, originally isolated from Petrosia seriata,280,281 were found to 
inhibit HIV-1 replication and HIV-1 reverse transcriptase.282 The total synthesis of the (+)-antipode 
of nakadomarin A 295, originally isolated from an Amphimedon species,283 has established the 
absolute stereochemistry of the (–)-natural enantiomer as (RRRR).284 Three new manzamine 590 
alkaloids 296–298, the related harman-1-one 299, and des-N-methylxestomanzamine A 300 were 
isolated from an Indonesian sponge.285 Three β-carbolines, 3-bromofascaplysin 301, 14-
bromoreticulatine 302 and 14-bromoreticulatate 303, have been reported as metabolites of 
Fascaplysinopsis reticulata from Indonesia and Fiji. 3-Bromofascaplysin was also reported as a 
metabolite of the tunicate Didemnum sp.286 Three iodine-containing indole alkaloids, 595 
plakohypaphorines A–C 304–306, were also obtained from the same Caribbean Plakortis simplex 
collection that yielded simplakidine (vide supra). This is the first report of naturally occurring 
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iodoindole alkaloids.287 Damirones A and B288 have been prepared from the corresponding 
makaluvamines by alkaline hydrolysis, suggesting that the damirones may be artifacts of isolation 
and not naturally-occurring compounds.289 The Indonesian sponge Biemna fortis yielded the 600 
pyridoacridine alkaloid labuanine 307, which along with two related synthetic pyridoacridine 
alkaloids and the previously isolated biemnadin,290 were found to be inducers of neuronal 
differentiation.291 Several new antimicrobial aaptamine type alkaloids 308–312 were isolated from 
an Indonesian Xestospongia species,292 while from a Japanese Neopetrosia sp. a further 
tetrahydroisoquinoline alkaloid, renieramycin J 313, was reported.293 The dark blue, cytostatic and 605 
antimicrobial metabolite, cribrostatin 6 314, was isolated from a species of Cribrochalina from the 
Maldives.294 The dictyodendrins A–E 315–319, isolated from the Japanese sponge Dictyodendrilla 
verongiformis were found to inhibit telomerase activity.295 Phloeodictine A1, originally isolated 
from a New Caledonian sponge of the genus Phloeodictyon,296 has been synthesised.297 N,N-
Dimethyl naamine D 320 and leucettamine C 321 are reported as new, mildly antimicrobial 610 
metabolites of two Fijian Leucetta species.298 The same research group has also isolated three 
further imidazole-containing alkaloids, calcaridine A 322 spirocalcaridine A 323 and 
spirocalcaridine C 324, from one of the two Leucetta collections.299 Isonaamidines A and C, 
originally isolated from an Indo-Pacific Leucetta species,300 have been synthesised.301 Sventrin, 
isolated from Agelas sventes,302 has been synthesised by a Red-Al reduction of an alkyne.303 An 615 
MT1-MMP inhibitor, ageladine A 325, was isolated from a Japanese Agelas nakamuri 
collection.304 Oroidin-type alkaloids with novel skeletons, the latonduines A 326 and B 327, were 
obtained from an Indonesian Stylissa carteri collection.305 A Stylissa aff. massa, obtained from 
Japanese waters, was found to contain a geranylgeranyltranferase type I inhibitor, massadine 
328.306 Crambescidin 826 329, isolated from a Monanchora sp. collected in Palau, was found to be 620 
a potent inhibitor of HIV-1 envelope-mediated fusion, along with the known compounds 
crambescidin 800307 and fromiamycalin,308 while dehydrocrambine A 330, also isolated from this 
sponge, was found to be a weak inhibitor only.309 A related antibacterial guanidine alkaloid, Sch 
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575948 331, was isolated from a Ptilocaulis spiculifer (Crambe crambe) specimen.310 Two 
antimitotic guanidine/bromotyrosine alkaloids, ceratamines A 332 and B 333, were isolated from a 625 
Papua New Guinean Pseudoceratina sp.311 An Indian collection of Psammaplysilla purpurea was 
found to contain the antibacterial bromotyrosine-derived alkaloids purpuramine K 334 and L 
335.312 Aerothionin, originally isolated from Verongia aerophoba,313 has been found to be active 
against drug-resistant strains of Mycobacterium tuberculosis and several other Mycobacterium 
sp.314 A Chinese collection of the sponge Phakellia fusca yielded a remarkable series of fluorinated 630 
uracil derivatives 336–340. The presence of fluorine was confirmed by X-ray diffraction and 19F 
NMR studies. This is the first report of fluorine-containing marine natural products.315 Sponge-
derived merosequiterpenoids continue to be a fruitful area of research for both natural product and 
synthetic chemists. Isoarenarol 341, isolated from a Papua New Guinean collection of Dysidea 
arenaria, was found to be a potent protein kinase inhibitor.316 Spongiaquinone, isolated from 635 
Stelospongia conulata,317 has been prepared in an asymmetric synthesis. The absolute 
stereochemistry was assigned based on comparison of the optical rotation of the synthetic methyl 
ether with that of the natural compound.318 A Micronesian Aka species has yielded three new 
sesquiterpenoid quinols, akaol A 342, 343, and the tentatively assigned siphonodictyol I 344.319 
Also isolated was siphonodictyal C 345, originally isolated from Siphonodictyon coralliphagum320 640 
and previously described as a free phenol. However the sample isolated from the Aka sp. had 
identical NMR spectra and clearly shows the presence of SO3Na by ESIMS.
319 The sulfate group is 
lost in EIMS, the technique used for characterisation in the original isolation procedure.320 
Siphonodictyal C was a modest inhibitor of complexation in the CDK4/cyclin D1 assay.320 The 
moderately cytotoxic neodactyloquinone 346 and the dactylolactones A–D 347–350 were obtained 645 
from an Okinawan collection of Dactylospongia elegans.321 A Great Barrier Reef species of 
Spongia yielded the sesquiterpenoid aminoquinone cyclosmenospongine 351, which was found to 
be moderately cytotoxic to murine Ehrlich carcinoma cells.322 Methanolic extracts of an Indonesian 
sponge of the genus Hyrtios yielded three new puupehenone derivatives 352–354, but which are 
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proposed to be artifacts of isolation from puupehenone.323 The biosynthesis of the sesquiterpenoid 650 
dichloroimines, stylotellanes A and B,324 was investigated. Incorporation of labelled farnesyl 
isocyanide and farnesyl isothiocyanate demonstrated the role of these compounds as intermediates 
in the formation of the stylotellanes.325 10-Formamido-4-cadinene 355, isolated from the Japanese 
sponge Acanthella cavernosa, was found to inhibit the settling of the cyprid (barnacle) larvae 
Balanus ainphitrite.326 The Indonesian sponge Axinyssa aculeata and its nudibranch predator 655 
Phyllidia varicosa were both found to contain the moderately antifungal 9-thiocyanatopupukeanane 
sesquiterpenoids 356 and 357.327 2-Thiocyanatoneopupukeanane 358, originally isolated from the 
sponge Phycopsis terpnis,328 was subsequently revised to the endo stereochemistry on the basis of 
long-range 1H-1H coupling and NOE correlations.329 Both enantiomers have been synthesised from 
(R)-carvone via the corresponding alcohols330 and the stereochemistry of 358 has now been fully 660 
established via an X-ray structure of the nitrobenzoate derivative of the corresponding alcohol.331 A 
Japanese Axynissa species yielded the mildly cytotoxic diterpene, axinyssene 359.332 An 
enantioselective synthesis of (–)-nakamurol, originally isolated from the Okinawan sponge Ageles 
nakamuri,333 established the relative and absolute stereochemistries of the naturally-occurring 360 
enantiomer.334 Synthesis of the proposed structure of aplyroseol-14 361, originally isolated from 665 
the New Zealand sponge Aplysilla rosea,335 did not yield spectra similar to those of the natural 
product. The revised structure, 362, was synthesised and found to be spectrally identical with 
aplyroseol-14.336 Six cycloamphilectenes isolated from an Axinella species collected in Vanuatu 
were found to be potent inhibitors of nitric oxide production by murine macrophages.337 Only one 
(N-formyl-7-amino-11-cyclocamphilectene) of the six compounds in this study has had a structure 670 
determination published.338 The C-25 sesterterpenoids and related nor-compounds are characteristic 
of sponges, especially those of Dictyoceratid origin. A cytotoxic norsesterterpenoid, 
mycaleperoxide 363, was isolated from a Mycale species collected in Thailand. The relative and 
absolute stereochemistries were established by standard methodology, including chemical 
interconversions.339 Two moderately cytotoxic norsesterterpenoids, sarcotins N 364 and O 365, 675 
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along with a sesterterpenoid 366, four pyrrolosesterterpenoids 367–370 and ent-kurospongin 371 
were isolated from two Korean Sarcotragus species.340 The previously reported sarcotin I 372341 
was found to have the (21R) configuration.340 Three norsesterterpenoids 373–375 and two 
sesterterpenoids 376 and 377, isolated from an Okinawan Ircinia species, were found to be 
moderately cytotoxic.342 Darwinella australensis collected from NW Australia contained 680 
sesterterpenoid sulfates 378–380 that inhibited the cell division of sea urchin eggs, but were not 
cytotoxic to human leukemia cells.343 An Ircinia species collected at -70 m by dredging in the Gulf 
of Mexico contained a tricyclic sesterterpenoid, Sch 599473 381,344 while the Antarctic sponge, 
Suberites caminatus yielded the rearranged sesterterpenoid aldehyde caminatal 382.345 An 
asymmetric synthesis of (–)-cacospongionolide F, isolated from Fasciospongia cavernosa,346 685 
confirmed the original stereochemical assignments.347 The bicyclic lactone astakolactin 383 and the 
pentacyclic diacetate 16-acetoxy-dihydrodeoxoscalarin 384 were obtained from specimens of 
Cacospongia scalaris collected in Greece.348 A Spongia species collected in Japan yielded three 
cytotoxic pentacyclic sesterterpenoids 385–387.349 Seven new polyhydroxy sterols 388–394 were 
isolated from a Japanese Acanthodendrilla species along with three known agosterols. These were 690 
found to be proteasome inhibitors.350 Clathriol B 395, isolated from the New Zealand sponge 
Clathria lissosclera, was found to inhibit the production of superoxide from human neutrophils.351 
A sterol sulfate, Sch 572423 396, along with the previously described halistanol sulfate,352 isolated 
from a Topsentia species collected in the Bahamas, were found to bind to P2Y12 receptors.
353 
Another deep-water Bahaman sponge, belonging to the family Astroscleridae, yielded the 695 
trisulfated sterol Sch 575867 397,354 while a series of steroidal oligoglycosides, the mycalosides B–
I 398–405, have been isolated from the Cuban sponge Mycale laxissima. The mycalosides are 
inhibitors of the fertilisation of sea urchin eggs.355 Four significantly cytotoxic steroidal alkaloids, 
plakinamines I–K 406–408 and dihydroplakinamine K 409, were isolated from a Philippine sponge 
Corticium niger.356 The halogenated and rearranged norsteroid, nakiterpiosin 410, isolated from the 700 
Okinawan Terpios hoshinota, was found to be cytotoxic to murine P388 leukemia cells.357 
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Hippospongic acid A, originally isolated from a Japanese Hippospongia species,358 inhibits all 
classes of vertebrate DNA polymerases and human topoisomerases I and II, but is inactive towards 
DNA polymerases from plants, insects and prokaryotes.359 Two mildly cytotoxic polyoxygenated 
triterpenes, yardenones A 411 and B 412 were isolated from a Yemenese collection of Axinella cf. 705 
bidderi.360 
 
8 Coelenterates 
 
The number of new metabolites reported annually from coelenterates has remained relatively 710 
constant over the 2002-2003 period. A new sphingosine derivative 413 was reported from a soft 
coral Nephthea sp. collected at the Andaman and Nicobar Islands, Indian Ocean,361 while 
investigations of Sinularia grandilobata and Sinularia sp. specimens from the same location 
afforded 414–416 as antimicrobial metabolites.362 The absolute stereochemistry of the N-palmitate 
417, isolated from a Bay of Bengal collection of Nephthea sp., was deduced by analysis of 1H-1H 715 
coupling constants of the acetonide derivative and comparison of optical properties with known 
compounds.363 Acylspermidines 418–420, isolated from an Okinawan collection of Sinularia sp. 
soft coral,364 were all potently cytotoxic towards A431 cells. In a separate study 419 and 420 were 
found to be potent inhibitors of plant vacuolar H+-pyrophosphatase.365 The phenol 421 was isolated 
from a Taiwanese collection of Isis hippuris,366 while investigation of a Japanese collection of the 720 
stony coral Tubastraea sp. afforded bisindole alkaloids 422–424.367 From Israel, eight new oxylipin 
derivatives were reported from Gulf of Aqaba collections of Dendronephthya sp. (425–428), 
Tubipora musica (429 and 430) and Dendrophyllia sp. (431 and 432) coelenterates.368 
Stereochemical configurations were secured by standard methods. All eight metabolites exhibited 
biological activity towards bacteria, brine shrimp, sea urchin egg development and crown gall 725 
potato tumours. Fifteen new members of the clavulone family of prostanoids 433–447 were 
reported from an Okinawan collection of Clavularia viridis.369 The absolute configurations of 433–
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443, 445 and 446 were secured by analysis of CD data while those of 444 and 447 were proposed 
based upon biogenetic considerations. Prostanoids 448–450, possible biosynthetic precursors to the 
clavulones, were also isolated from an Okinawan collection of C. viridis.370 By utilising protease 730 
and detergent fractionation methodology, clavulones and arachidonic acid have been located in host 
C. viridis membranes, as opposed to the closely associated symbiont Symbiodinium sp.371 
Sesquiterpenes ainigmaptilones A 451 and B 452 were isolated from a Weddell Sea, Antarctica, 
collection of Ainigmaptilon antarcticus.372 Ainigmaptilone A demonstrated activity in a number of 
ecologically-relevant assays, including antibiotic and feeding deterrence properties. 735 
Furanosesquiterpene 453, reported from the Antarctic gorgonian Dasystenella acanthina, bears a 
trans-ring junction as determined by NOESY NMR experiments and comparison with related cis-
fused isomers.373 Asymmetric synthesis of both enantiomers of acetoxytubipofuran 454, originally 
isolated from a Japanese collection of Tubipora musica,374 defined the absolute stereochemistry as 
shown,375 while the structure of echinofuran376 has been confirmed by racemic synthesis.377 740 
Confertol 455 and nephalbidol 456 were isolated from the soft corals Sinularia conferta and 
Nephthea albida respectively,378 while cladioxazole 457 was isolated from an Andaman Island, 
Indian Ocean, collection of Cladiella sp.379 A full account of the synthesis of the dolabellane 
diterpene claenone, previously reported from Clavularia sp.,380 the first synthesis of palominol, 
from Eunicea laciniata,381 and a new route to dolabellatrienone, also from E. laciniata,381,382 have 745 
also been reported.383 Stereoselective synthesis of (+)-4,5-deoxyneodolabelline, a metabolite of an 
Australian collection of Cespitularia sp.,384 has been reported.385 The structure of kallosin A 458, a 
rearranged pseudopterane diterpenoid isolated from a Caribbean collection of Pseudopterogorgia 
kallos, was secured by spectroscopic and X-ray analyses.386 Elisabethin A, isolated from P. 
elisabethae,387 has been synthesised utilising intramolecular [4+2] cyclisation under biomimetic 750 
conditions.388 The first synthesis of the related diterpene elisapterosin B and a new route to 
colombiasin A, also isolated from P. elisabethae,389,390 have been achieved based on [5+2] and 
[4+2] intramolecular cyclisations of a common diene intermediate.391 New members of the 
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elisapterosin family, D 459 and E 460, were reported from a Caribbean collection of the same 
organism.392 P. elisabethae is also a well recognised source of anti-inflammatory diterpenes, new 755 
examples of which include elisabethadione 461, elisabethol 462, pseudopterosins M–O 463–465 
and seco-pseudopterosins E–G 466–468.393 Of the eight diterpenes, 461, 464 and 466 were the most 
potent in the mouse ear edema assay. The chemical steps involved in the biosynthesis of the 
pseudopterosins in P. elisabethae have been studied using 3H-labelled precursors,394 with a 
subsequent study showing that diterpene production is occurring within the dinoflagellate symbiont 760 
Symbiodinium sp.395 Preparation of all four C-1 and C-7 stereoisomers of pseudopteroxazole 469, a 
mildly antimycobacterial diterpene isolated from P. elisabethae,396 required a revision of assigned 
stereochemistry to that shown,397 while a new bioactive congener, homopseudopteroxazole 470, has 
been reported from the same organism collected near San Andrés Island, Colombia.398 The 
structures of the P. elisabethae metabolites, elisabatins B399 and C,400 have been confirmed by X-765 
ray studies.401 Investigation of a Great Barrier Reef collection of Sarcophyton cherbonnieri yielded 
furano-cembranoids 471–473, while the same study402 also reported new seco-cembranoids 474 and 
475 from a Fijian collection of Nephthea sp. in addition to the known cembrane decaryiol.403 
Modest cytotoxicity towards a panel of tumour cell lines was exhibited by 471, 473 and decaryiol 
while the latter was shown to arrest the cell cycle at G2/M. Structures of sarcocrassolide B 476404 770 
and sarcophyocrassolide A 477,405 cytotoxic cembrane diterpenes isolated from a Chinese collection 
of Sarcophyton crassocaule, were secured by X-ray studies,406 as was that of 11-epi-sinulariolide 
acetate 478,407 previously reported from gorgonians collected from the Gulf of Elat. 11-epi-
Sinulariolide acetate was found to exhibit moderate cytotoxicity towards a range of tumour cell 
lines. In addition to a number of known metabolites, new nor-cembrane diterpenes leptocladolides 775 
A 479, B 480 and C 481 were isolated from a Taiwanese collection of Sinularia leptoclados, while 
479 and related compounds 1-epi-leptocladolide A 482 and (7E)-leptocladolide A 483 were isolated 
from an ethanolic extract of S. parva.408 Both 479 and 483 exhibited modest cytotoxicity towards 
two tumour cell lines, but 482 was less active. Two known diterpenes, sinuleptolide 484409 and 
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norcembrenolide 485,410 inhibit LPS-induced TNF-α production by murine macrophage-like cells 780 
in a dose-dependent manner.411 Note that while the characterisation data for the two diterpenes 
reported in the reference agree with original and recent reports,408 the structures are represented 
with incorrect relative stereochemistry at C-11. Cembranes 486–489 were isolated from an eastern 
Caribbean collection of Eunicea tourniforti.409 The structure and relative stereochemistry of the 
highly oxygenated diterpene providencin 490, purified from Caribbean collections of 785 
Pseudopterogorgia kallos, was secured by X-ray analysis.410 Mild cytotoxicity towards human 
tumour cell lines was observed for 490. In addition to the known metabolites stolonidiol 491 and 
stolonidiol monoacetate 492, two new dolabellane diterpenes, clavinflols A 493 and B 494, were 
isolated from a Taiwanese collection of Clavularia inflata.411 While 491, 492 and 494 exhibited 
selective cytotoxicity towards the KB cell line, 493 was selective towards the Hepa cell line. In 790 
contrast, the acetoxy derivatives 495 and 496 were essentially inactive in the same assays. 
Pachyclavulariolides M–R 497–502 were isolated from a Taiwanese collection of Pachyclavularia 
violacea.412 P388 cell line growth inhibition was observed for 497. (Z)-Sarcodictyin A 503 is a 
potently cytotoxic diterpenoid isolated from a Japanese collection of Bellonella albiflora.413 The 
absolute stereochemistry of 503 was related to sarcodictyin A 504 by transesterification and 795 
comparison of CD spectra. Spectroscopic discrepancies observed for the enantioselectively 
synthesised structure originally proposed for alcyonin 505, isolated from the Okinawan soft coral 
Sinularia flexibilis,414 has led to the proposal that the correct structure of the natural product is the 
allylic peroxide 506.415 The structures of briarellins E 507 and F 508, isolated from a Puerto Rican 
collection of Briareum asbestinum,416 were confirmed by enantioselective total synthesis, which 800 
also established the absolute configuration of the diterpenes.417 In addition to a number of known 
compounds, new briarellins J–P 509–515, two unnamed congeners 516 and 517 and polyanthellin A 
518 were reported from a Puerto Rican collection of Briareum polyanthes.418 Spectroscopic 
evidence was also presented for revision of the structure of briarellin A from 519419 to peroxide 
520, and reformulation of the structures of 521 and 522, isolated from an Australian collection of 805 
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Briareum sp. in 1989,420 to the enantiomers of 518 and 523 respectively. Antimalarial testing 
against Plasmodium falciparum indicated 511, 516 and 517 to be the most active. Two 
investigations of the chemistry of Junceella juncea, one using specimens collected from the 
Tuticorin coast of the Indian Ocean, yielded juncins I–M 524–528,421 while a Taiwanese collection 
of the same organism afforded juncin N 529.422 Additional studies of J. juncea from Taiwan 810 
afforded juncenolides B-D 530-532423 and juncenolide E 533,424 of which 531 exhibited mild 
cytotoxicity towards Hepa and KB cell lines.423 A different diterpene structure 534, isolated from an 
Indian Ocean collection of J. juncea, was also given the trivial name juncenolide B.425 A Taiwanese 
collection of Junceella fragilis yielded 9-O-deacetylumbraculolide A 535.426 The structurally 
related epoxides briaexcavatolides S–V 536–539 were isolated from Taiwanese specimens of 815 
Briareum excavatum,427 while a Taiwanese collection of J. fragilis was the source of junceellolide 
H 540.428 Briarlides A–H 541–548, obtained from Amami Oshima, Kagoshima Prefecture 
collections of Briareum sp., were evaluated for cytotoxicity towards Vero and MDCK cell lines 
where modest activity was observed for 541, 544–546, weak activity for 542, 543 and 547 while 
548 was inactive.429 In addition to a number of known metabolites, seven new briaranes, 820 
erythrolides R–U 549–552, an erythrane, erythrolide V 553, and two aquariane-skeletoned 
diterpenes, aquariolides B 554 and C 555, were reported from a Caribbean collection of 
Erythropodium caribaeorum.430 Aquariolide A 556, previously isolated from aquarium-grown 
specimens of E. caribaeorum,431 was also identified from the organism collected in the wild. The 
relative stereochemistries of 549–555 were determined either by conversion to known related 825 
derivatives, or by interpretation of ROESY NMR data, while for erythrolide S 550, Mosher 
methodology established the absolute configuration of the 3-hydroxybutanoyl side chain as (3’S). 
The biosynthetic relationships between a number of erythrolide diterpenes, involving possible 
enzymatic-mediated di-π-methane and vinyl-propane rearrangements was discussed. The study also 
reported that the known metabolites erythrolides P432 and J433 exhibited modest cytotoxicity towards 830 
the MCF7 tumour cell line. An Okinawan collection of Xenia sp. yielded the known metabolite 
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xeniolide A434 as well as new xenicane diterpenes dihydroxeniolide A 557 and isoxeniatriacetate 
558.435 The absolute configuration of 557 was established (Mosher method), while the absolute 
configuration of 558 was determined by synthesis from the stereochemically-defined xeniolide A.436 
13-Epi-9-deacetoxyxenicin 559 was isolated as a cytotoxic component of Asterospicularia laurae 835 
collected on the Great Barrier Reef, Australia.437 Good activity was observed for 559 against 
P388D1 cells, while the known metabolite 13-epi-9-deacetylxenicin 560438 was less active. DCM or 
ether solutions of 559 readily underwent autoxidation to afford the hydroperoxide 561, while 560 
was found to be resistant to further reaction. The stereochemistries of sesterterpenes cladocorans A 
562 and B 563, isolated from Mediterranean collections of Cladocora cespitosa,439 have been 840 
revised by total synthesis,440 while preparation and testing of related stereoisomers indicated the 
series exhibits cytotoxicity towards a panel of human tumour cell lines.441 Pregnane acetal 564 was 
isolated from an ethanol extract of Subergorgia suberosa, collected off the Mandapam coast, Indian 
Ocean,442 while a Taiwanese collection of Isis hippuris afforded the polyoxygenated steroids 
hippuristerones E–I 565–569.443 New gorgosterol and ergosterol derivatives 570–574 were isolated 845 
from a Great Barrier Reef collection of Capnella lacertiliensis.444 All compounds exhibited weak 
antifungal activity while 573 and 574 also weakly inhibited tyrosine kinase p56lck. The spiroketal 
steroid 575 was isolated from a Tuticorin coast, Indian Ocean collection of Gorgonella 
umbraculum,445 while the mildly cytotoxic gibberoketosterol 576 was isolated from a Taiwanese 
collection of Sinularia gibberosa.446 A South China Sea collection of Nephthea chabroli afforded 850 
the weakly cytotoxic sterols 577 and 578,447 and the arabinopyranosylsterol 579 was isolated from 
Cladiella krempfi, also collected in Chinese waters.448 APETx1, a 4,552 Da 42-amino acid peptide 
cross-linked by three disulfide bonds, was isolated from the sea anemone Anthopleura 
elegantissima.449 The toxin inhibits HERG voltage-dependent K+ channels via gating modification 
rather than channel pore occlusion. Pore formation by equinatoxin II, a protein toxin isolated from 855 
the Mediterranean sea anemone Actinia equina,450 has been examined using combinations of 31P 
NMR, 31P MAS NMR, electron microscopy,451 FTIR452 and toxin mutagenesis.453 The ability of 
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surface plasmon resonance to study membrane binding processes of pore forming toxins has been 
reviewed.454  
 860 
9 Bryozoans 
 
Once again, few new compounds have been reported from bryozoans. The structural determination 
of the alkaloids pterocellins A 580 and B 581, isolated from the marine bryozoan Pterocella 
vesiculosa collected in New Zealand, relied in part on an X-ray diffraction study of pterocellin A 865 
580. Both pterocellins A and B exhibit potent antimicrobial and antitumour activity in vitro, but 
only displayed modest activity in an in vivo hollow fibre assay.455 The β-carboline alkaloid 8-
hydroxyharman 582 was isolated from a sample of the New Zealand marine bryozoan Cribricellina 
cribraria.456 A number of brominated alkaloids and a diterpene from the North Sea bryozoan 
Flustra foliacea457,458,459,460,461 were tested against bacteria derived from marine and terrestrial 870 
environments. These compounds exhibited significant activities against one or more marine 
bacterial strains originally isolated from F. foliacea, but only weak activities against the terrestrial 
bacteria. Dihydroflustramine C462 and flustramine D461 exhibited N-acyl-homoserine lactone 
(AHL)-antagonistic activity as determined by using the biosensors Pseudomonas putida (pKR-
C12), P. putida (pAS-C8) and E. coli (pSB403).458 A synthesis of the cytotoxic isoquinoline 875 
alkaloid perfragilin A, originally isolated from the bryozoan Membranipora fragilis,463 has been 
reported.464 
 
10 Molluscs 
 880 
There was a slight increase in new chemistry identified from molluscs in 2003 over that reported for 
the time frame of the previous review. Irregular polypropionates placidenes C–F 583–586 and 
hydroperoxide 587 were isolated from a Mediterranean collection of Placida dendritica.465 It is 
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likely that 587 is derived from the known metabolite placidene A 588,466 but whether the 
hydroperoxide is an artifact of isolation, or a true natural product is unclear. The first synthesis 885 
(racemic) of the unsaturated polypropionate photodeoxytridachione, isolated from Placobranchus 
ocellatus467 and other molluscs,468 has been reported.469 Five new azaspiracid analogues 589–593, 
identified using tandem mass spectrometric techniques, were isolated from Mytilus edulis collected 
off the west coast of Ireland.470 The stereochemistries of the new azaspiracid analogues are 
arbitrarily shown as matching that of azaspiracid-1 594,471 the structure and stereochemistry of 890 
which has been called in to question by stereoselective synthetic studies.472,473 The isolation of N-
methyl-D-glutamic acid 595 from the Japanese mollusc Scapharca broughtonii is the first report of 
this amino acid derivative as a natural product.474 Monterey Bay, California, collections of 
Calliostoma canaliculatum afforded the disulfide-linked dimer of 6-bromo-2-mercaptotryptamine 
596 as a channel-gating antagonist of voltage-gated potassium channels.475 6-Bromoindirubin 597, 895 
isolated from the Mediterranean mollusc Hexaplex trunculus, and the synthetic oxime 598 were 
found to be potent inhibitors of glycogen synthase kinase-3 (GSK-3).476 The molecular geometry of 
GSK-3β inhibition by 598 was determined by a co-crystallisation X-ray study. Radio- and stable 
isotope incorporation studies have identified nicotinic acid and acetate as biosynthetic precursors of 
haminol-2,477 a de novo biosynthesised metabolite of the Mediterranean mollusc Haminoea 900 
orbignyana.478 The ability of the fungal alkaloid gliotoxin to act as a bioaccumulated toxin of 
shellfish has been examined using Mytilus edulis.479 Lamellarin D, a polycyclic alkaloid first 
isolated from molluscs of the genus Lamellaria,480 has been found to be a potent inhibitor of the 
DNA-processing enzyme topoisomerase I.481 Japanese and US collections of Aplysia kurodai and A. 
californica were sources of the gut and vasculature contraction inhibitory pentapeptide Pro-Arg-905 
Gln-Phe-Val-amide (PRQFVa).482 Precursoral peptide cDNA was successfully cloned while 
PRQFVa-positive neuron distribution in CNS and peripheral tissue was mapped using in situ 
hybridisation and immunocytochemistry. Five excitatory peptides, r11a–e 599–603 were isolated 
from the venom of the fish-hunting cone snail Conus radiatus collected in the Philippines.483 
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Further molecular analysis of cDNA clones defined the isolated peptides as belonging to a new 910 
class, the I-superfamily, of conotoxins, which contain a scaffold with four disulfide bonds (linkages 
not defined). The solution conformation of αA-conotoxin EIVA 604, originally isolated from the 
Atlantic cone shell C. ermineus,484 was determined by NMR experiments and restrained molecular 
dynamics calculations.485 A South China Sea collection of Conus betulinus yielded κ-conotoxin 
BtX 605, a 31 residue four disulfide bond-containing K+ channel up-modulator.486 As noted in 915 
Section 4, the revised structure487 of kahalalide F 126, a potently cytotoxic488 depsipeptide isolated 
from the mollusc Elysia rufescens and the algal dietary source Bryopsis sp.,142 has been confirmed 
by careful analysis of degradation products and chiral derivatisation.144 The mechanism of 
biological action of dolastatin 11, a cytotoxic depsipeptide isolated from the sea hare Dolabella 
auricularia,489 involves stabilisation of F-actin, which has been studied using X-ray fibre diffraction 920 
of oriented filament sols.490 Also isolated from a Japanese collection of the sea hare D. auricularia, 
dolabellanin B2, a 33 amino acid residue peptide, exhibits a broad spectrum of antimicrobial 
activity.491 The solution structure of attractin, a 58-residue water-borne protein pheromone isolated 
from Aplysia californica has been determined by NMR methods.492 Austrodoral 606 and 
austrodoric acid 607 are new nor-sesquiterpenes isolated from the Antarctic nudibranch Austrodoris 925 
kerguelenensis, but with 607 most likely being an artifact of isolation.493 As noted in Section 7, the 
thiocyanatopupukeanane sesquiterpenes 356 and 357 were isolated as an epimeric mixture from the 
nudibranch Phyllidia varicosa and the nudibranch’s dietary sponge Axinyssa aculeata.327 While 
both compounds were isolated from the digestive gland of the nudibranch, epimer 357 was found to 
accumulate in the mantle, suggestive of a role in chemical defense. Both compounds exhibited mild 930 
toxicity towards brine shrimp and antimicrobial activity with 357 being more potent. De novo 
biosynthesis, via mevalonic acid, of fatty acid ester derivatives of drimane 608 and sesquiterpene 
609494 in the nudibranch Doriopsilla areolata has been determined by feeding studies utilising [1-
13C]glucose, [1,2-13C2]glucose and [1,2-
13C2]acetate.
495 Investigation of the diterpenoid acylglycerol 
fraction of an extract of the mantle of the Antarctic nudibranch Austrodoris kerguelenensis afforded 935 
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the acylglycerols 610 and 611.496 Also isolated were two known 1,2-diacylglyceryl esters, 
previously reported from the same organism,497,498 the structures of which were corrected to 612 
and 613 based upon interpretation of HMBC NMR correlations. The de novo biosynthesis of the 
structurally related diterpenoid glyceride verrucosin A499,500 by the Mediterranean nudibranch Doris 
verrucosa has been investigated using both 13C- and 14C-labelled precursors.501 Four new labdane 940 
diterpenes 614–617 were isolated from the pulmonate Trimusculus peruvianus, collected near the 
Antofagasta Coast of Chile.502 Absolute stereochemistry was secured by standard methods. 
Compounds 616 and 617 exhibited mild cytotoxicity towards human tumour cell lines in vitro. The 
structure of aplysiallene 618, deduced for a metabolite isolated from a Japanese collection of the sea 
hare Aplysia kurodai,503 has been retracted504 and corrected to the known bromoallene algal 945 
metabolite 619.505 The first diastereoselective synthesis of (–)-spongian-16-oxo-17-al, originally 
isolated from the nudibranch Ceratosoma brevicaudatum,506 has confirmed the absolute 
stereochemistry of the metabolite, while synthesis of the related compound (–)-acetyldendrillol-1 
620, isolated from the nudibranch Cadlina luteomarginata,507 has led to correction of 
stereochemistry at C-17.336 A further collection of Trimusculus peruvianus, again from the 950 
Antofagasta Coast of Chile, yielded two mildly cytotoxic polyhydroxylated steroids 621 and 622.508 
The stereochemistries of 621 and 622 were determined by interpretation of NOESY NMR data and 
comparison of chemical shifts with stereochemically-defined related compounds. 
 
11 Tunicates (ascidians) 955 
 
The number of new secondary metabolites reported from ascidians has remained essentially static 
for each of 2002 and 2003. Three new glycosphingolipid molecular species, the major component 
of each being represented by 623–625, were isolated from a Mediterranean collection of 
Microcosmus sulcatus.509 A full account of the synthesis of lobatamide C, a cytotoxic macrolide 960 
isolated from Aplidium lobatum collected off the southwestern coast of Australia,510 has been 
 38 
reported.511 In addition, preliminary V-ATPase inhibition structure-activity data was reported 
indicating the importance of the salicylate ring and enamide moieties for activity. The absolute 
configuration of iejimalide B 626, a cytotoxic 24-membered macrolide isolated from a Japanese 
collection of Eudistoma cf. rigida,512 has been defined by analysis of 1H-1H and 1H-13C coupling 965 
constants, distance geometry calculations and analysis of oxidative degradation products.513 During 
the study the gross structure was also corrected to that shown (13Z). Floresolides A 627, B 628 and 
C 629 are moderately cytotoxic cyclofarnesylated hydroquinones isolated from an Aplidium sp. 
ascidian collected at Flores Island.514 The structures and absolute configurations of all three 
metabolites were secured by X-ray analysis of 629. The structures of the 3-aza-[7]-paracyclophane-970 
containing alkaloids haouamines A 630 and B 631, isolated from Aplidium haouarianum collected 
off Tarifa Island, Cádiz, were also secured by X-ray analysis.515 Both haouamines exhibited two 
sets of NMR signals, attributed to the presence of isomers resulting from either atropisomerism or 
slow pyramidal inversion of the bridgehead amine. Of the two compounds, haouamine A was the 
more potent antitumour agent. Ascidians are a well-established source of cyclic peptides, many of 975 
which exhibit cytotoxicity. Didmolamides A 632 and B 633 are cyclic hexapeptides containing all 
(S)-configuration amino acids isolated from Didemnum molle collected in Madagascar.516 Both 
compounds exhibited modest cytotoxicity towards a panel of tumour cell lines. Six new congeners 
of the bistratamide family of cyclic hexapeptides, E–J 634–639, were reported from a Tablas Island, 
Philippines collection of Lissoclinum bistratum.517 All six compounds showed weak to moderate 980 
activity towards the HCT-116 tumour cell line. A full account of the synthesis of mollamide, a 
cytotoxic cycloheptapeptide isolated from an Australian collection of Didemnum molle,518 has been 
reported.519 The solution structure of the cytotoxic cycloheptapeptide trunkamide A 640520,521 has 
been determined using 2D-NMR data and simulated annealing methods.522 Fluorescent analogues of 
ascidian-derived depsipeptides didemnin B and tamandarin A have been used to study short-term 985 
predator-prey relationships between fish and marine invertebrate larvae.523 Plicatamide, a modified 
octapeptide isolated from the blood of a San Diego Bay specimen of Styela plicata,524 and several 
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synthetic analogues have been found to exhibit potent antimicrobial activity, to cause K+ efflux in 
Staphylococcus aureus, were potently hemolytic for human red blood cells, and formed cation-
selective channels in model lipid bilayers.525 Structure-activity studies of halocidin, an antimicrobial 990 
peptide (3443 Da) isolated from hemocytes of the solitary ascidian Halocynthia aurantium,526 
identified one congener with potent antimicrobial activity, but reduced hemolytic activity.527 
Further biological investigation of the cytotoxic depsipeptide aplidine, isolated from Aplidium 
albicans,528 indicates that the compound inhibits the growth and induces apoptosis in MOLT-4 cells 
through inhibition of vascular endothelial growth factor (VEGF) secretion which blocks the VEGF-995 
VEGFR-1 autocrine loop necessary for growth of these cells.529 In addition, aplidine prevents the in 
vitro aggregation of the prion peptide PrP 106-126.530 EPR studies of vanadium-binding proteins, 
isolated from the vanadocytes of the ascidian Ascidia sydneiensis samea, indicate that up to 24 
vanadium ions bind per protein molecule in a mononuclear state and that coordination is through 
amine nitrogens.531 The absolute configuration of etzionin 641, an antifungal diketopiperazine 1000 
hydroxamate originally isolated from an unidentified Red Sea ascidian,532 has been secured by 
synthesis of all four stereoisomers of derivative 642, and direct comparison of optical rotation 
values with the same natural derivative.533 An initial attempt at expanding the structure-activity 
relationship of the cytotoxic quinolizidine alkaloid clavepictine B isolated from the Bermudian 
ascidian Clavelina picta,534 has indicated the importance of sidechain unsaturation, and that relative 1005 
stereochemistry about the ring system does not seem to be important for cytotoxicity.535 Two full 
accounts of the stereoselective synthesis of lepadiformine, a biologically active alkaloid isolated 
from the ascidians Clavelina lepadiformis and C. moluccensis,536,537 have been reported.538,539 The 
structurally related ascidian alkaloids (+)-cylindricines C–E, isolated from an Australian collection 
of Clavelina cylindrica,540 were prepared using ruthenium-catalysed hydrative diyne cyclisation 1010 
methodology.541 The quaternised indole-enamine conicamin 643 was isolated as a histamine 
antagonist from a Mediterranean collection of Aplidium conicum.542 Cynthichlorine 644, previously 
known as a synthetic product from the chlorination of methylindolyl methylester,543 was isolated 
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from a Moroccan collection of Cynthia savignyi.544 The alkaloid exhibited antifungal activity 
towards two tomato pathogenic fungi and bacteria and was also cytotoxic in the brine shrimp 1015 
lethality assay. Studies of an unidentified ascidian collected in Madagascar have afforded the mildly 
cytotoxic alkaloids barrenazine A 645 and B 646.545 The structures of the barrenazines were secured 
by use of 1H-15N HMBC NMR experiments, while the observance of optical rotatory properties for 
645 suggested the (R*,R*) configuration. Further investigation of the Mediterranean collection of 
Aplidium conicum yielded conicaquinones A 647 and B 648, both of which exhibited cytotoxicity 1020 
towards a rat glioma cell line.546 Kottamide E 649, the first example of a natural product bearing the 
amino acid 4-amino-1,2-dithiolane-4-carboxylic acid (Adt), was isolated from the New Zealand 
ascidian Pycnoclavella kottae.547 Benzotrithioles related to the cytotoxic pentathiepin ascidian 
alkaloids varacin548 and lissonclinotoxin A549,550 have been prepared and optical rotatory properties 
and crystal structures investigated.551 Lissoclinotoxins E 650 and F 651 were isolated as mildly 1025 
cytotoxic components of a Philippine didemnid ascidian.552 The relative orientation of the aromatic 
rings of 650 and 651 were deduced, as shown, based upon molecular modeling studies. New 
members of the rigidin family of pyrrolopyrimidine alkaloids, rigidins B–D 652–654, were isolated 
from an Okinawan collection of Cystodytes sp.,553 while rigidin E 655 was isolated from a Papua 
New Guinea collection of a Eudistoma species.554 Rigidins B–D were mildly cytotoxic towards the 1030 
L1210 murine leukemia cell line553 while rigidin 656555 and rigidin E were not cytotoxic towards 
A431 and wild-type and p53 deficient HCT-116 human tumour cell lines.554 Two β-carboline 
alkaloids, eudistomins W 657 and X 658, were isolated from Chuuk Atoll, Micronesia collections 
of a Eudistoma species.556 The absolute stereochemistry of 657 was ascertained (Mosher method), 
and 658 was found to be more potent in antimicrobial assays. Shishijimicins A–C 659–661 are 1035 
extraordinarily potent cytotoxic enediyne antibiotics isolated from a South Japan collection of 
Didemnum proliferum.557 Relative and absolute stereochemistries were determined by standard 
methods and by comparison of CD data with that reported for the calicheamicins, terrestrial 
microbe-derived enediyne antibiotics. Distomadines A 662 and B 663 are new 6-hydroxyquinoline 
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alkaloids from the New Zealand ascidian Pseudodistoma aureum.558 The structure of styelsamine C, 1040 
an hydroxylpyridoacridine alkaloid isolated from the Indonesian ascidian Eusynstyela latericius,559 
has been confirmed by synthesis.560 As noted in Section 7, 3-bromofascaplysin 301 was isolated 
from extracts of a Didemnum species ascidian collected at Chuuk Atoll, Micronesia, as well as from 
Fijian collections of Fascaplysinopsis sponges.286 The structure of sebastianine A, a pentacyclic 
alkaloid isolated from a Brazilian collection of Cystodytes dellechiajei,561 has been confirmed by 1045 
total synthesis.562 Continued study of ascididemin, isolated from a Japanese collection of a 
Didemnum sp.,563 indicates that derivatives are also active in antiparasitic assays,564 that the 
antitumour activity can be varied somewhat predictably,565,566 and that a mechanism of reductive 
activation to form reactive oxygen species also contributes to the cytotoxicity of the parent 
alkaloid.567 The structure of bengacarboline, a cytotoxic alkaloid isolated from a Fijian collection of 1050 
a Didemnum sp.,568 has been confirmed by total racemic synthesis.569 A convenient solid-phase 
synthesis of the ascidian metabolites lamellarin L570 and U571 has been reported.572 New improved 
syntheses of (–)-diazonamide A 664 have been reported,573,574 and investigation of the mechanism 
of action of 664 and analogue 665 indicate that the alkaloids are potent inhibitors of microtubule 
assembly, possibly at a unique site.575 Efficient syntheses of the naturally occurring cytotoxic 1055 
ecteinascidins ET-729, -745, -759B, -736, -637 and -594576,577,578,579,580 from the fermentation 
product cyanosafracin B have been reported.581 The parent compound, ET-743, continues to 
progress through clinical trials.582,583,584 Ritterazine B, a dimeric steroidal alkaloid isolated from 
Ritterella tokioka,585 induces apoptosis in HL-60 cells and causes cell cycle accumulation at G2/M, 
but has no caspase activation effect nor does it alter phosphorylation of bcl-2.586 Aplidiasterols A 1060 
666 and B 667 are new cytotoxic secosterols isolated from a Mediterranean collection of Aplidium 
conicum.587 The structure and absolute stereochemistry of a steroidal sperm-activating and 
attracting factor 668 isolated from the ascidian Ciona intestinalis588 has been unambiguously 
determined by total synthesis.589 
 1065 
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12 Echinoderms 
 
A similar number of new compounds were reported from echinoderms in 2003 compared with 
2002. This field continues to be dominated by glycosylated ceramides and saponins. Taurine 
derivative 669 was isolated from a Gomun Island, Korea, collection of the starfish Certonardoa 1070 
semiregularis.197 Investigation of the Patagonian starfish Anasterias minuta afforded a range of 
metabolites including the new glucosylceramide anasterocerebroside A 670.590 The known 
ceramide 671591,592 was also characterised for the first time. A Japanese collection of the starfish 
Luidia maculata yielded four ceramide lactosides, luidialactosides A–D 672–675.593 The position of 
the olefin in the long chain base of 674 was deduced by FABMS analysis of a dimethyl disulfide 1075 
derivative. Three ganglioside molecular species, SCG-1–3, the major species of which are 
represented by 676–678, were isolated from the Japanese sea cucumber Stichopus chloronotus.594 
All three species displayed neuritogenic activity against PC12 cells in the presence of nerve growth 
factor. A structurally more complex ganglioside molecular species SJG-2 679, isolated from a 
Japanese collection of Stichopus japonicus, also exhibited neuritogenic activity.595 Brine shrimp 1080 
lethality assay-directed fractionation of the starfish Certonardoa semiregularis, collected off 
Komun Island, Korea, afforded thirteen new polyhydroxysterols. These were certonardosterols A–
M 680–692,596 as well as the known 693.597 Side chain configurations at C-24 (for 686 and 693), C-
25 (for 680) and both C-24 and C-25 (for 688) were determined (Mosher method). All of the 
sterols, with the exception of 692, exhibited modest in vitro cytotoxicity towards a panel of human 1085 
tumour cell lines. A range of hemolytic steroid disulfates, including new examples 694 and 695, 
were reported from the starfish Pteraster pulvillus collected by trawling in the Sea of Okhotsk in the 
Far East.598 Unusual alkaloid cation and steroidal anion compounds 696–698 were isolated from the 
starfish Lethasterias nanimensis chelifera collected by trawling near the Kuril Islands in the Far 
East.599 Comparison of optical rotation values identified the cation as being the (R)-isomer of 1090 
salsolinol. Steroid glycosides (saponins), commonly isolated from echinoderms, present challenges 
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in structural elucidation and exhibit a diverse range of biological activities, both aspects of which 
have been reviewed.600,601 Four new saponins, certonardosides K–N 699–702, isolated from the 
starfish Certonardoa semiregularis collected off Komun Island, Korea, exhibited varied biological 
activity towards a range of tumour cell lines and bacteria.602 Configuration at C-24 in 699, 701 and 1095 
702 was secured by methanolysis and analysis of MTPA ester derivatives. The polyhydroxylated 
steroid ketone 703 and monoglycosylated steroid 704 were reported from collections of the Far 
Eastern starfish Henricia sanguinolenta and H. leviuscula leviuscula.603 Both compounds mildly 
inhibited division of fertilised sea urchin eggs. A South China Sea collection of the sea cucumber 
Mensamaria intercedens yielded intercedensides A–C 705–707, novel triterpene glycosides that 1100 
exhibited in vitro cytotoxicity towards a panel of human tumour cell lines.604 Intercedenside A also 
exhibited in vivo activity towards Lewis lung and mouse S180 sarcoma tumour models. A Sea of 
Japan collection of the sea cucumber Cucumaria conicospermium also afforded triterpene 
glycosides, cucumariosides A2-5 708, A3-2 709, A3-3 710 and isokoreoside A 711, all of which 
contain the same pentasaccharide moiety, but differ in the number and position of the sulfate groups 1105 
and the aglycone.605 Limited quantities of two new saponins ruberoside E 712 and F 713 were 
isolated from specimens of the starfish Asterias rubens collected in the Baltic Sea.606 The structures 
of both compounds were secured using a cryogenic NMR probe in an LC-NMR-MS configuration. 
Two mildly cytotoxic saponins, luidiaquinoside 714 and psilasteroside 715, were reported from 
collections of the starfish Luidia quinaria collected at Sendai (Japan) and Psilaster cassiope 1110 
collected in the northern Gulf of Mexico respectively.607 The pathological effects of sea urchin 
toxins has been reviewed.608 
 
13 Miscellaneous 
 1115 
Three alkylpyrrole sulfamates 716–718 were isolated as fish-feeding deterrent metabolites from the 
annelid Cirriformia tentaculata, collected in Florida.609 Close to forty years after the structure of 
 44 
tetrodotoxin was elucidated,610,611,612 the first asymmetric syntheses of the alkaloid have been 
reported.613,614 
 1120 
14 Conclusion 
 
In the early years of marine natural products research there was less emphasis on biological testing, 
but increasingly there has been a focus on the biological properties of these compounds. In the first 
of the Faulkner reviews (1977),615 mention was made of the antibiotic properties of only a handful 1125 
of compounds and reference made to the P388 activity of some Dolabella auricularia metabolites. 
In this review of the literature for 2003, over 720 compounds are included with biological activities 
being reported for 354 of these. The distribution of biological activities and source phyla for these 
compounds in 2003 is shown graphically in Figures 1 and 2. The sponges and coelenterates 
continue to dominate as source phyla of new compounds, with microorganisms being the other 1130 
major source. The relative incidence of bioactivity detected was greatest from the green alga 
followed by tunicates, echinoderms and sponges, but in absolute numbers the sponges dominated. 
The reported biological testing has been grouped into five categories, but is dominated by various 
tests for anticancer and antimicrobial/antiinfective properties. Tunicates, echinoderms and sponges 
were prime sources for the detection of potential anti-cancer properties. This combination of source 1135 
and biological activity is very much in keeping with the data presented in the timely review on 
marine natural products and related compounds in clinical and advanced clinical trials.616 A 
graphical representation of the tabular data presented in that review is shown in Figure 3. Progress 
towards marine anticancer drugs dominates with the prime source phyla being sponges followed by 
microorganisms, tunicates and molluscs. The other categories where marine natural products are 1140 
progressing are in drugs for pain and asthmatic conditions where the interest is centered on Conus 
toxins and analogues of sponge sterols respectively.616 
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Since the discovery of the arabinose-based nucleosides by Bergman over 50 years ago,617-619 
the explosion of interest in alternative nucleoside compositions and the subsequent development of 
Ara-C and Ara-A as drugs with obvious linkages to later antiviral drugs such as acyclovir and AZT, 1145 
there has been a tacit assumption that marine-based drugs would soon be forthcoming. That has not 
yet happened, but the first truly marine drugs should be licensed within the next two years.616 
Yondelis, better known as ecteinascidin 743, is in Phase II and III trials in Europe and the USA 
against soft tissue sarcoma, while the Conus toxin known as Ziconotide or Prialt is in Phase III 
clinical trials for intractable pain with plans for launching as a new drug in 2005. Despite problems 1150 
in 2003 with the European Agency for the Evaluation of Medicinal Products, Yondelis will 
probably also be launched in 2005.616 
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Captions for Figures 1–3 
 
Fig. 1 Distribution of biologically-active and non-active marine natural products by phylum, 2003. 
 2095 
 (Non-active – compounds for which no biological activity has been reported; Active – compounds that are 
active in at least one bioassay) 
 
 
 2100 
Fig. 2 Distribution of biological activity by phylum. 
 
 (AC – cancer related assays including cytotoxicity, antimitotic, histone deacetylase, proteasome, TNF, a range 
of kinases, DNA binding and matrix metalloproteinase; AM – antimicrobial, antiinfective, antiTb, antimalarial 
assays; AO – antioxidant assays; IV – in vivo assays such as brine shrimp and sea urchin eggs; Other – 2105 
includes antiviral assays, assays based on central nervous system responses, feeding deterrent assays, ion 
channel assays, antifouling assays and assays for Fe siderophores, neuronal differentiation, oocyte lysis, sperm 
attractant and UV-A activity)  
 
 2110 
 
Fig. 3 Numbers and distribution of marine and marine-derived compounds in clinical and pre-
clinical trials.  
 
(Data extracted from Table 1 in reference 616) 2115 
 (C – anticancer drugs; AI – antiinflammatory drugs; P – drugs for intractable pain; A – Alzheimers) 
 
